Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

FRESENIUS SE : Buy rating from JP Morgan

10/26/2020 | 03:44am EST

David Adlington from JP Morgan retains his positive opinion on the stock with a Buy rating. The target price remains set at EUR 60.40.


© MarketScreener with dpa-AFX Analyser 2020
Stocks mentioned in the article
ChangeLast1st jan.
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.48% 69.94 Delayed Quote.6.03%
FRESENIUS SE & CO. KGAA -0.97% 37.66 Delayed Quote.-24.95%
All news about FRESENIUS SE & CO. KGAA
11/24FRESENIUS SE : UBS remains Neutral
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : RBC reiterates its Neutral rating
MD
11/19FMC FRESENIUS MEDICAL CARE AG & CO K : Bernstein reiterates its Neutral rating
MD
11/19FRESENIUS SE : Bernstein reiterates its Buy rating
MD
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of quarter..
EQ
11/19FRESENIUS SE & CO. KGAA : Preliminary announcement of the publication of financi..
EQ
11/17FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies reiterates its Neutral rating
MD
11/13FRESENIUS SE : Receives a Buy rating from Bernstein
MD
11/12FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Neutral rating from Bernstein
MD
11/09Switzerland's Vifor strikes kidney drug deal with Angion
RE
More news
Financials
Sales 2020 36 301 M 43 267 M 43 267 M
Net income 2020 1 790 M 2 133 M 2 133 M
Net Debt 2020 24 198 M 28 842 M 28 842 M
P/E ratio 2020 12,0x
Yield 2020 2,10%
Capitalization 21 201 M 25 191 M 25 269 M
EV / Sales 2020 1,25x
EV / Sales 2021 1,12x
Nbr of Employees 309 114
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 49,67 €
Last Close Price 38,03 €
Spread / Highest target 78,8%
Spread / Average Target 30,6%
Spread / Lowest Target -53,5%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO. KGAA-24.21%25 191
AIER EYE HOSPITAL GROUP CO., LTD.103.94%39 788
IHH HEALTHCARE1.65%11 895
BANGKOK DUSIT MEDICAL SERVICES0.00%11 785
RAMSAY HEALTH CARE LIMITED-10.84%10 895
TOPCHOICE MEDICAL CORPORATION98.77%10 395